An ageing population, rising antimicrobial resistance, and the ongoing threat of infectious and chronic diseases are placing immense pressure on our societies. A shift to a preventative approach is necessary for the efficiency and sustainability of our healthcare systems. Central to this shift is the often-underutilized tool of life-course immunization.
Here we learn from Biljana Stangeland, PhD, Executive Director, Chief Scientific Officer and Co-founder at Alv B AS, about exciting new developments in therapeutic feline and canine cancer vaccine.
Separate to WHO efforts to conduct a technology transfer, Moderna signed a Memorandum of Understanding with Kenya to build the first mRNA factory in Africa.
Having just one dose of the COVID-19 vaccine significantly reduced multiple psychological distress factors, improving the well-being and safety of recipients.
Across the US, those living in rural counties have been more affected by variants of the COVID-19 vaccine, with a faster rate of spread as well as more deaths due to lower rates of vaccination.
